Outbreak and Regression of COVID-19 Epidemic Among Chinese Medical Staff

被引:6
作者
Li, Na [1 ,2 ]
Yu, Xiang [3 ]
机构
[1] Ningbo Univ, Sch Law, Ningbo, Zhejiang, Peoples R China
[2] Ningbo Univ, Res Acad Belt & Rd, Ningbo, Zhejiang, Peoples R China
[3] Fujian Jiangxia Univ, Sch Publ Affairs, 2st Xiyuangong Rd, Fuzhou 350108, Fujian, Peoples R China
关键词
COVID-19; exposure; risk; transmission; treatment; CORONAVIRUS OUTBREAK; GLOBAL HEALTH; WUHAN; TRANSMISSION; 2019-NCOV; RISK;
D O I
10.2147/RMHP.S268178
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Coronavirus disease 2019 (COVID-19) broke out first in Wuhan City, Hubei Province, China. In the process of controlling the pandemic, many Chinese medical staff (MS) were infected. We used government data, post mortem reports, and the medical literature on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission, as well as prevention-and-control guidelines from the government, hospitals and media, to discuss the main risks factors faced by MS. We suggest that, when dealing with a similar pandemic in the future, guidance on personal protective equipment must be provided and materials reserved in advance. Also, the emergency response of medical institutions should be enhanced, and information shared with other countries facing identical severe challenges.
引用
收藏
页码:1095 / 1102
页数:8
相关论文
共 54 条
[1]  
[Anonymous], COR DIS 2019 COVID 1
[2]  
[Anonymous], 2020, RADIOLOGY, DOI DOI 10.1148/radiol.2020200490
[3]  
[Anonymous], 2020, SCI CHINA LIFE SCI, DOI DOI 10.1007/s11427-020-1637-5
[4]  
[Anonymous], 2020, ANN TRANSL MED, DOI DOI 10.21037/ATM.2020.02.2020
[5]  
[Anonymous], 2020, JAMA, DOI DOI 10.1001/JAMA.2020.2648.13
[6]  
[Anonymous], 2020, CAN ASS RADIOL J
[7]  
Chen TM, 2020, BIORXIV, DOI [10.1101/2020.01.23.91639544., DOI 10.1101/2020.01.23.91639544]
[8]   Preparedness and proactive infection control measures against the emerging novel coronavirus in China [J].
Cheng, V. C. C. ;
Wong, S-C. ;
To, K. K. W. ;
Ho, P. L. ;
Yuen, K-Y. .
JOURNAL OF HOSPITAL INFECTION, 2020, 104 (03) :254-255
[9]  
Chinese Center for Disease Prevention and Control, EP UPD RISK ASS 2019
[10]  
Chinese National Health Commission, ANN